|
Cost effectiveness analysis of bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004% |
|||
| Bimatoprost 0.03% |
Latanoprost 0.005% |
Travoprost 0.004% |
|
|
|
|||
| Annual Cost* |
$455 |
$537 |
$591 |
| IOP Reduction, Lower Value†(mm Hg) |
7 |
6 |
7 |
| IOP Reduction, Upper Value†(mm Hg) |
8 |
8 |
8 |
| Cost Effectiveness Range ($/mm Hg decrease in IOP) |
$57–$65/mm Hg |
$67–$90/mm Hg |
$74–$84/mm Hg |
|
IOP = intraocular pressure *Average retail price, 2005, before adjustment for drug shelf life. †Ranges of IOP reduction efficacy reported in package inserts [7–9]. | |||
Frenkel et al. BMC Ophthalmology 2007 7:16 doi:10.1186/1471-2415-7-16 |
|||